Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$4.45 – $4.45
Exchange
OTC Link
ADRC
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.30B | $2.80B | $3.19B | $5.21B | $7.09B | $7.38B | $6.60B | $6.83B |
| Cost of revenue | $1.31B | $1.50B | $1.68B | $2.94B | $4.28B | $4.54B | $4.36B | $4.96B |
| Gross profit | $991.7M | $1.30B | $1.51B | $2.27B | $2.81B | $2.85B | $2.24B | $1.87B |
| Gross margin | 43.1% | 46.5% | 47.4% | 43.6% | 39.6% | 38.6% | 34.0% | 27.4% |
| R&D | $88.0M | $124.0M | $156.6M | $211.8M | $234.6M | $261.6M | $238.4M | $257.6M |
| Operating income | $595.9M | $1.08B | $1.12B | $1.92B | $2.58B | $2.49B | $664.4M | $1.01B |
| EBITDA | $691.7M | $1.18B | $2.42B | $3.89B | $2.95B | $2.85B | $1.13B | $1.42B |
| Net income | $472.2M | $841.6M | $1.75B | $2.87B | $2.01B | $2.02B | $405.1M | $887.9M |
| Net margin | 20.5% | 30.0% | 54.8% | 55.1% | 28.3% | 27.4% | 6.1% | 13.0% |
| EPS (diluted) | 0.63 | 1.13 | 2.19 | 3.30 | 2.32 | 2.34 | 0.47 | 1.04 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $7.7B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $8.8B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
HANGZHOU TIGRMD UNSP/ADR
No one on the platform currently holds HNGZY.
No tracked institution reports a position in HNGZY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-22 | $0.0185 | 2026-08-14 |
| 2025-06-13 | $0.0413 | 2025-08-14 |
| 2024-06-11 | $0.0798 | 2024-08-01 |
No one on the platform has traded HNGZY yet.
| -0.21% |
| $5.3B |
| — |
| DPHAYDechra Pharmaceuticals PLC | $98.00 | +1.98% | $5.6B | — |
| GALNFGalenica AG | $115.00 | +0.00% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.